Biosensors for Rapid Detection of Avian Influenza by Wang, Ronghui & Li, Yanbin
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 4
Biosensors for Rapid Detection of Avian Influenza
Ronghui Wang and Yanbin Li
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/64353
Provisional chapter
Biosensors for Rapid Detection of Avian Influenza
Ronghui Wang and Yanbin Li
Additional information is available at the end of the chapter
Abstract
The scope of this chapter was to review the advancements made in the area of biosensors
for rapid detection of avian influenza viruses (AIVs). It is intended to provide general
background about biosensor technology and to discuss important aspects for developing
biosensors, such as selection of the suitable biological recognition elements (anti-AIV
bioreceptors) as well as their immobilization strategies. A major concern of this chapter
is also to critically review the biosensors’ working principles and their applications in AIV
detection. A table containing the types of biosensor, bioreceptors, target AIVs, methods,
etc. is given in this chapter. A number of papers for the different types of biosensors give
hints on the current trends in the field of biosensor research for its application on AIV
detection. By discussing recent research and future trends based on many excellent
publications and reviews, it is hoped to give the readers a comprehensive view on this
fast-growing field.
Keywords: biosensor, avian influenza virus, rapid detection, bioreceptor, nanobiosen-
sor
1. Introduction
Influenza viruses, which belong to the Orthomyxoviridae family, are classified as A, B, and C
based on antigenic differences in their nucleoprotein (NP) and matrix (M1) protein [1]. All avian
influenza viruses (AIV) are classified as type A. Type A viruses are further subtyped on the basis
of antigenic differences of the surface glycoproteins, the hemagglutinin (HA), and the neura-
minidase (NA) proteins [2]. So far, seventeen HA (H1 through H17) and ten NA (N1 through
N10) subtypes have been identified [3]. Figure 1 presents a schematic diagram of influenza A
virus, and Figure 2 shows a transmission electron microscopy photograph. Influenza A virus
is an enveloped RNA virus approximately 80–120 nm in diameter [1, 2]. There are two major
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surface glycoproteins (HA and NA) and a small number of M2 protein, which has ion channel
activity. The ratio of HA and NA is approximately 4:1. The genome of type A virus consists of
eight segments of negative-sense single-stranded RNA, which are associated with many NP
and the transcriptase complex (RNA polymerase components PB1, PB2 and PA) to form
ribonucleoproteins (RNPs). The matrix protein M1 has an interaction with the RNPs and is under
the lipid bilayer. NS1 is found only in infected cells and is not thought to be a structural component
of the virus, but small amount of NS2 are present in purified viruses.
Figure 1. A schematic diagram of the structure of the influenza A virus particle.
Figure 2. A transmission electron micrograph of influenza A virus particles.
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AIVs have a large impact on the poultry each year and also represent a threat to human health.
The highly pathogenic H5N1 avian influenza (HPAI H5N1), which originally emerged in
Southeaster Asia in late 1990s, cost the poultry industry an estimated $10 billion between 1997
and 2008 [4]. HPAI H5N1 has also caused global concerns for public health and continues to
spread throughout the world. Since 2003, a total of 62 countries (regions) have been affected
by HPAI H5N1 and new human and animal cases are continuously being confirmed and
reported [5]. The link between human and AI has raised concern among public health
authorities and the scientific community about the prevalence and pandemic potential of AI
virus. The H5N1 virus has caused 449 deaths of 846 people infected since 2003, according to
the World Health Organization [5]. Therefore, advanced technologies for more rapid and
sensitive AIV detection are needed for better surveillance and control of the outbreaks.
Current virus detection techniques are available, such as virus isolation, immunofluorescence
antibody (FA) test, immunohistochemistry (IHC), and ELISA as well as rapid procedures based
on molecular tools, such as polymerase chain reaction (PCR)-based assays, gene sequencing,
and microarrays. Among these test methods, virus isolation has been the “gold standard” as
its highest sensitivity and reliability, but it is a very time-consuming procedure (4–7 days).
ELISA is a simple and rapid test in testing mass serum samples; thus, it is commonly used for
serum antibody detection, but not used for virus detection in practice or diagnostics. Other
immunoassays of FA or IHC can be used as a direct virus detection test from tissue specimens,
but they either require labels or have limitations of low sensitivity and cross-reactions in certain
circumstances. The molecular assays of RT-PCR and real-time RT-PCR methods have the
advantages of high sensitivity and good specificity, but possess disadvantages of requiring
expensive PCR equipment and reagents, and well-trained skillful technical personnel.
Therefore, in order to minimize the social and economic costs, the development of rapid
detection methods is essential. These rapid detection methods should meet the following
requirements: (1) high throughput, (2) possibility of multiple target detection, (3) high
sensitivity, (4) good specificity, (5) high speed, (6) simple operation, (7) suitability for on-site
and/or in-field use, and (8) less cost. Biosensors have shown a great potential to meet such
criteria.
The biosensor research began in the early 60 s of the twentieth century, when a glucose
biosensor was proposed by Clark and Lyons [6] at Children’s Hospital in Cincinnati. From then
on, biosensor applications have expanded throughout the medical diagnosis field and also into
the fields of environmental monitoring, agricultural production, food safety, pharmaceutical
screening, and biodefense. A biosensor can be defined as a “compact analytical device or unit
incorporating a biological or biologically derived sensitive recognition element integrated or
associated with a physiochemical transducer” [7]. This device is composed of a biological
recognition element (often called bioreceptor) and directly interfaced signal transducer
(Figure 3). The selective and reversible process of interaction between the analyte and
bioreceptor is transduced into a measurable signal, for example, electrical signal, which is
proportional to the concentration or activity of an analyte in any type of samples. Biosensors
can be classified based on the transduction element or the biological element. According to the
basic principles of signal transduction, there are three main biosensor types, which have been
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studied for use in AIVs detection: piezoelectric, optical, and electrochemical biosensors. If we
follow the types of biological element or bioreceptors, AIV biosensors can be classified into
immunosensors, aptasensors, DNA or RNA-probe sensors, and more. In this chapter, we focus
on these types of biosensors studied and developed recently for rapid detection of AIVs. It
offers a survey of the principles, fabrication, operation, and the most popular types of bio-
sensing devices in research or application today for AIVs detection. By discussing recent
research and future trends based on many excellent publications and reviews, it is hoped to
give the readers a comprehensive view on this fast-growing field.
Figure 3. A schematic diagram of biorecognition and signal transduction in a typical biosensor.
2. Biosensors for detection of AIVs
As shown in Figure 4, the number of papers published in the field of biosensor research for
detection of AI has kept increasing from year 2001 to 2015 based on PubMed. Biosensors offer
the advantages of simple operation, rapid response, low cost, portability, automation, and easy
to integrate with nanomaterials/nanostructure, Micro-Electro-Mechanical System(MEMS)/
Nano-Electro-Mechanical System(NEMS), biotechnology, Global Position System(GPS)/
wireless, and image technologies. One of the major requirements in developing a biosensor
for AIVs is the need for a sensitive analytical device that can easily go down to very low
detection levels without significant changes in selectivity. AIVs will spread rapidly through a
community before any symptoms appear for the identification. A biosensor that can rapidly,
sensitively and selectively detect target virus will be invaluable. In addition, a simple, robust,
rapid, cost-effective, and potable biosensor, suitable for use in the field, is urgently needed.
While a variety of biosensors have been developed for use in different applications, three types
of biosensors have been mainly studied for AIV detection: piezoelectric, optical, and electro-
chemical biosensors.
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Figure 4. Numbers of papers published in the field of biosensor research for detection of AIVs between year 2001 and
2015.
2.1. Piezoelectric biosensors
Piezoelectric biosensors utilize crystals capable of generating a piezoelectric field to detect
mass changes in the sensing environment [8]. The crystal is sandwiched between two excitation
electrodes, which apply an electrical field that causes the crystal to undergo dimensional
changes, or oscillations, at the crystals natural resonant frequency. An increase in the mass on
the surface of the crystal, such as antibody immobilization or capture of antigen, decreases the
resonant frequency. Piezoelectric biosensors are useful because they are low cost, label free,
sensitive, and have extremely low detection levels [8]. The most intensively studied piezo-
electric biosensor is the quartz crystal microbalance (QCM), which uses a thin wafer of quartz
as the transducing crystal. Quartz crystals have the advantages of being widely available,
relatively inexpensive, durable, direct detection, and real-time output. Other techniques are
often coupled with QCM to increase the performance and capability of the biosensor. QCM
biosensors have attracted interest in applications for AIVs detection. Table 1 summarizes the
main analytical features of QCM biosensors for detection of AIVs. Different studies used
different concentration units for AIV. It would be helpful to know the comparable relationship
between them. The common concentration units for AIV contain EID50 (50% egg infectious
does), ELD50 (50% egg lethal does), PFU (plague-forming units), and HAU (hemagglutination
unit). 1 × 103 EID50 ml−1 equals to ~0.0128 HAU/50 μl [9], 1 × 106.2 ELD50 ml−1 equals to 128 HAU/
50 μl [10], and 1 × 105 PFU equals to 1 HAU [11].
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Influenza
subtype
Target Bioreceptor Sensitivity Detection
range
Detection
time
Labelling
method
Reference
H3N2 Virus Antibody 4 virus
particles/ml
0.02–3 HAU – Label-free [12]
H1N1 Virus Antibody 104 pfu/ml 103–107 pfu/ml 45 min Label-free [13]
103 pfu/ml 105 min Label with
13 nm gold
nanoparticles
H5N1 Virus Antibody 0.0128 HAU 0.128–12.8 HAU 120 min Label with
30 nm
magnetic
nanobeads
[14]
H5N1 Virus Aptamer 1 HAU 1–4 HAU 60 min Label with
30 nm
magnetic
nanobaeds
[22]
H5N1 Virus Aptamer
hydrogel
0.0128 HAU 0.0128–
0.64 HAU
30 min Label-free [9]
H5N3 HA Glycan Kd 1.44 ×
10−8 M
– – Label-free [26]
H5N3 Virus N-Acetylglucosamine
(GlcNAc)
Ka 2.03 × 1010 M – – Label-free [27]
H5N1 Ka 4.35 × 1010 M
H1N3 Ka 2.56 × 1012 M
Table 1. QCM biosensors for detection of AIVs.
Antibodies are the most common bioreceptor of choice for sensing, and they are generated by
immunizing an animal system with antigen. The interaction between antibody and antigen
can be transduced into measurable signal changes. Early studies focused on the development
of QCM immunosensor based on antibody-antigen interaction for influenza virus detection
[12–14]. For example, the characterization of a QCM biosensor for the direct detection of
influenza A viruses was reported by Owen et al. [12]. Self-assembled monolayers (SAMs) of
mercaptoundecanoic acid (MUA) were formed on QCM gold electrodes for the immobilization
of anti-influenza A antibodies, and the limit of detection was estimated to be 4 virus particles/
ml. QCM immunosensor has been used also to detect avian influenza label free in nasal
washings with a lower detection limit of 104 pfu/ml, although, with the addition of a gold
nanoparticle conjugate, the detection limit was reduced to 103 pfu/ml, which is comparable to
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the sensitivity and specificity of viral isolation techniques [13]. Li et al. [14] reported a nano-
beads amplified QCM immunosensor with polyclonal antibody as the recognition ligand for
detection of AIV H5N1.
In recent years, aptamers have been investigated as an alternative of sensing elements, which
have the potential to replace the antibodies. This is possible due to the unique features of
aptamers (sensitivity, specificity, reusability, stability, nonimmunogenicity), which can be
easily exploited in biosensor technology. Aptamers are single-stranded RNA or DNA oligo-
nucleotides which rely on hydrogen bonding, electrostatic and hydrophobic interactions
rather than Watson-Crick base pairing for recognition to their target. Aptamers can fold into
distinct secondary and tertiary structures, bind to their targets with high affinity (dissociation
constants on the order of nano- to picomolar), and recognize their targets with a specificity
that challenges antibodies and other biological ligands. They are selected in vitro through
systematic evolution of ligands by exponential enrichment (SELEX). The selection procedure
involves the iterative isolation of ligands out of the random sequence pool with affinity for a
defined target molecule and PCR-based amplification of the selected RNA or DNA oligonu-
cleotides after each round of isolation. As biorecognition ligands, aptamers possess numerous
advantages, including small size, rapid and reproducible synthesis, simple and controllable
modification to fulfill different diagnostic and therapeutic purposes, slow degradation
kinetics, nontoxicity, and a lack of immunogenicity.
The majority of aptamers developed for AIVs have focused on inhibition of the hemagglutinin
protein preventing viral infection. For example, a DNA aptamer was developed by Jeon and
co-workers [15]. RNA aptamers that inhibit membrane fusion of AIV H3N2 and influenza B
virus hemagglutinin also were developed [16, 17]. DNA and RNA aptamers that target HA1
proteins of influenza virus hemagglutinin subtype H5 were investigated in two different
studies [18, 19]. An aptamer that binds efficiently to the HA of highly pathogenic AIV H5N1
and H7N7 was studied by Suenaga and Kumar [20], which inhibits HA-glycan interactions.
These aptamers were developed to inhibit function of the hemagglutinin protein and prevent
or treat influenza infection. Based on the function and likely binding sites of these aptamers,
it seems unlikely these aptamers would be optimal sequences to use in a biodetection assay.
A DNA aptamer for avian influenza H5N1 was developed by Wang et al. [21] using a combi-
nation of protein and whole virus targets. It is unique in its binding affinity in that it specifically
targets the H5N1 subtype, having no binding activity with other H5 or N1 subtype viruses.
This suggests that the binding site be at an intersection of the H5 and N1 proteins.
Aptamer-based QCM biosensors, also called QCM aptasensors, have been developed for the
detection of AIVs. Brockman et al. [22] studied a QCM aptasensor for detection of AIV H5N1
using magnetic nanobeads labels as mass amplifiers. The biosensor was found to have a lower
detection limit of 1 HAU, although the detection time was reduced by half compared to a
similar QCM biosensor using antibodies [14]. A hydrogel-based QCM aptasensor (Figure 5)
was able to detect AIV H5N1 at 0.0128 HAU in 30 min [9]. The QCM aptasensor was based on
swelling of the hydrogel after AIV H5N1 capture due to dissolution of the cross-linked
aptamers and ssDNA in the hydrogel polymer. The developed aptasensor was both rapid and
sensitive.
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Figure 5. (a) Schematic of the QCM aptasensor; (b) a photograph of the QCM aptasensor setup. The aptamer hydrogel
is immobilized on the gold electrode surface. The quartz in the electrode acts as a transducer, converting the mass and
viscosity change to a frequency signal.
Influenza virus specificity for the host is mediated by the viral surface glycoprotein hemag-
glutinin (HA), which binds to receptors containing glycans with terminal sialic acids. This
molecular recognition process leads to the host cell-virus adhesion stage [23]. The sialic acid
receptor of various influenza virus strains differs in affinity to sialic acids terminally linked
either in α(2,3) or α(2,6) position to the galactose (Gal) residues. Human influenza A viruses
preferentially recognize the α(2,6)-linkage, while avian viruses have preference for the α(2,3)-
linkage [24, 25]. Each monovalent sialic acid-binding site of HA is weak, with dissociation
constants in the millimolar range, while the high virus-cell affinity is due to multivalency.
Takahashi and co-workers [26] demonstrated kinetics of HA binding to sulfatide and ganglio-
side GD1a by QCM analysis. QCM analysis showed that the HA bound with the Kd of
1.44 × 10−8 M to sulfatide immobilized on a sensor chip, which indicated that sulfatide directly
binds to the ectodomain of HA with high affinity. N-Acetylglucosamine (GlcNAc) is a natural
ligand and is part of the oligosaccharide ligand responsible for the influenza virus binding
first step. In a report by Wangchareansak et al. [27], GlcNAc was employed as bioreceptor
immobilized on QCM gold sensor surface for detection of influenza A virus (H5N3, H5N1,
H1N3), which displayed high binding affinity with Ka values of 2.03 × 1010, 4.35 × 1010, and
2.56 × 1012 M, respectively.
QCM biosensor has advantages, such as simplicity, cost-effectiveness, real-time output, and
direct detection. But there also exists some disadvantages, such as the lack of stability, difficulty
with sensor surface regeneration, loss of the immobilized ligands after multiple washing and
regeneration, nonspecific binding of other nontarget biomaterials, and relatively long incuba-
tion time. Further improvements are required to address these limitations before the QCM
biosensor technology can be routinely employed for AIVs detection.
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2.2. Optical biosensors
Optical biosensors rely on visual phenomena to detect the interaction between the biological
element and the target analyte. Examples of optical biosensors include surface plasmon
resonance (SPR), absorption, luminescence, and fluorescent sensors. Detection by optical
biosensors can occur in two ways: by the analyte directly affecting the optical properties of the
sensing environment, such as in SPR or absorption methods, or by the analyte being tagged
with a label that produces an optical phenomenon, such as in fluorescence methods. Optical
biosensors, which are sometimes referred to as “optodes,” have received considerable interest
in the detection of AIVs. The main analytical features of optical biosensors for detection of
AIVs are summarized in Table 2 [3, 28–38]. The target “virus” in Table 2 is the entire virus
particle and target “HA” is the HA protein or recombinant HA protein of virus.
Influenza
subtype
Target Bioreceptor Sensitivity Sensor Labelling
method
Reference
H1N1 Virus Glycan 45.6 × 10−13 M SPR Label-free [29]
H3N2 HA Antibody 1 nM Waveguide Dye [32]
H5N1 HA Glycan Kd 1.6 × 10−9 M SPR Label-free [30]
H5N1 Virus Aptamer 0.128 HAU SPR Label-free [31]
H1N1 HA Aptamer Kd 67 fM SPR Label-free [28]
H3N2 Virus Antibody 0.2 HAU/ml Prism-free SPR Fluorescent [33]
H3N2 Virus Antibody – Waveguide Gold
nanoparticles
[3]
H9N2 Virus Antibody 8.94 ng/ml Nanobioprobe
coupled with
immunomagnetic
beads, Fluorescent
[36]
H7 subtype HA gene Oligonucleotide
probe
7 pM Luminescence
resonance
energy
transfer (LRET)
[37]
H1N1 Virus Antibody 1.0 × 10−13 g/ml Silver
nanoparticles
labeled
antibodies
with indirect
fluorescence
[35]
H5N1 HA Aptamer 2 ng/ml
(buffer);
3.5 ng/ml
(human
serum)
Silver
nanoparticles;
Fluorescent
[34]
H1N1 Virus Antibody 0.1 pg/ml Gold nanoparticle-
decorated carbon
nanotubes;
photoluminescence
[38]
H3N2 50 pfu/ml
Table 2. A list of optical biosensors reported for the detection of AIVs.
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Various modes of optical measurement exist (i.e., absorption, reflection, fluorescence, chemi-
luminescence, and phosphorescence); however, biosensors based on surface plasmon reso-
nance (SPR) and fluorescence principles are the most common and promising methods for
AIVs detection.
The Kretschmann configuration [39] is the most popular optical setup for SPR applications.
SPR biosensors measure the change in refractive index due to binding of biomolecules near
the sensor surface. Refractive index is defined as the ratio of the speed of light in vacuum and
the phase velocity of light in the medium. SPR is one of very few techniques that are able to
provide noninvasive, real-time kinetic data on association, and dissociation rates, along with
equilibrium binding constants for receptor or ligand systems. Estmer-Nilsson et al. [40] were
able to utilize SPR to quantify influenza virus for vaccine production via an antibody inhibition
assay using HA proteins immobilized on the sensor surface. Some research showed SPR
biosensors for avian influenza DNA hybridization [41], adamantane binding sites in the
influenza A M2 ion channel [42], influenza virus hemagglutinin monitoring [43], and binding
kinetics study [44]. Studies by Gopinath et al. [28] revealed that SPR-based biosensor is a useful
tool for detection of human and avian influenza viruses.
SPR-based Biacore technology has been designed to investigate biomolecular interactions,
which was initiated in 1984. The commercial available systems include Biacore 1000, Biocore
3000, BIAlite, and Biacore T100. Biacore is the dominant SPR technique used for AIVs detection.
The main advantage of this technology is its capacity to monitor weak macromolecular
interactions that cannot be detected by other sensors and its subject ability to automation. SPR
was used to evaluate the binding of influenza A virus H1N1 directly to a neomembrane of
bovine brain lipid or an egg yolk lecithin fraction [29] and to monitor the interactions between
influenza HA and glycan [30] or apatmers [28]. However, Biacore instruments are expensive
and need proper maintenance. Bai and co-workers [31] have shown that a portable hand-held
SPR-based biosensor (Spreeta™, Texas Instruments, Dallas, TX, USA) (Figure 6) can be
employed for the detection of AIV H5N1. The fabrication of the SPR biosensor was based on
the streptavidin-biotin binding. The streptavidin was directly adsorbed on the gold surface,
and then, biotinylated ssDNA aptamers were immobilized. Target AIVs were captured by the
immobilized aptamers and resulted in an increase in the refraction index. It was able to detect
AIV H5N1 in poultry swab samples with a lower detection limit of 0.128 HAU in 1.5 h.
The working principle of a waveguide mode sensor is similar to that of a SPR sensor. The only
difference is that the measurement is conducted using a waveguide mode rather than a surface
mode [32]. Based on the properties of light-guiding and dimensions, there are two general
classes, fiber optical waveguides and planar waveguides, which can be further divided into
single mode and multimode [45]. Waveguide mode biosensors were developed using antibody
as bioreceptor for the detection of HA from H3N2 [32] and H3N2 virus [3].
Of the optical methods requiring labels for detection, fluorescence is the most widely studied
[34–36, 46, 47]. Fluorescence measurements are of particular interest in biosensor systems due
to their high sensitivity. Commonly used labels in fluorescent biosensors are dyes, quantum
dots (QDs), and fluorescent proteins, with the latter two becoming more popular as they are
further researched [46]. A fluorescent aptasensor was developed by Pang and co-workers [34]
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for detection of AIV H5N1. The Ag@SiO2 core-shell nanoparticles were coated with the anti-
HA aptamers. The binding of aptamer-HA protein formed a G-quadruplex complex, which
captured thiazole orange (TO) and reported the fluorescent signal of TO. Moreover, it caused
a surface plasmon resonance enhancement and performed as a metal-enhanced fluorescence
sensing. The detection of HA protein of the AIV H5N1 could be operated both in aqueous
buffer and human serum with the detection limit of 2 and 3.5 ng/mL, respectively. The total
detection time was only 30 min. Using antibodies as bioreceptors, Li et al. [35] developed a
highly sensitive fluorescent immunosensor for detection of H1N1, which was based on Ag
autocatalysis. It had a detection range of 1.0 × 10−12 to 1.0 × 10−8 g/ml with a detection limit of
10−13 g/ml.
Figure 6. Configuration for measuring AIV H5N1using the portable SPR aptasensor (with permission from MDPI).
Fluorescence resonance energy transfer (FRET) is used in the design of a biosensor, which is
based on the energy transfer between two light-sensitive molecules, a donor and an acceptor
chromophore. In the nucleic acid-based FRET method, a reporter and a quencher are conju-
gated at the terminals of a nucleic acid probe. Without the target, the duplex is formed, bringing
these two molecules in close proximity, which results in fluorescence quenching. The present
of a target can cause the conformational change of the probe, which changes the position of
the reporter and quencher and emits fluorescence. A QD-induced FRET system was developed
by Chou and Huang [47] using two oligonucleotides. These two oligonucleotides were
designed to specifically recognize two regions of the AIV H5 sequences and were employed
as the capturing and reporter probes, respectively. They were conjugated to QD655 (donor)
and Alexa Fluor 660 dye (acceptor), respectively. At target concentrations ranging from 0.5 nM
to 1 μM, the QD emission decreased at 653 nm and dye emission increased at 690 nm. Another
luminescence resonance energy transfer (LRET)-based biosensor was developed by Ye et al.
Biosensors for Rapid Detection of Avian Influenza
http://dx.doi.org/10.5772/64353
71
[37] for rapid and ultrasensitive detection of AIV H7 subtype. In this work, BaGdF5:Yb/Er
upconversion nanoparticles (UCNPs) and gold nanoparticles (AuNPs) were used as the pair
of donor and acceptor. The oligonucleotides with H7 HA gene sequence were conjugated with
thiol and then were assembled on the AuNPs surfaces. The complementary sequence probes
were modified with amino group and then were covalently bond to poly(ethylenimine)
modified BaGdF5:Yb/Er UCNPs. The hybridization process brought these two molecules in
close proximity, resulting in fluorescence quenching.
QDs are a type of semiconductor with a diameter typically between 2 and 10 nm whose excitons
are confined in three spatial dimensions, giving them properties of both unconfined semicon-
ductors and discrete molecules. In comparison with organic dyes and fluorescent proteins,
QDs have unique optical and electronic properties including size-tunable light emission,
improved signal brightness, high resistance against photobleaching, and simultaneous
excitation of multiple fluorescence colors. QD-based bioconjugates used for optical sensing
could dramatically increase the sensitivity that would permit simultaneous measurement of
several targets. Lee and co-workers [38] developed a plasmon-assisted fluoro-immunosensor
by the conjugation of antibody onto the surface of cadmium telluride QDs and the Au
nanoparticle-decorated carbon nanotubes (AuCNTs) for the detection of H1N1 and H3N2. A
detection limit of 0.1 pg/ml and 50 pfu/ml was obtained for H1N1 and H3N2, respectively.
Fluorescent biosensors are simple and show improved sensitivity and reduced detection time.
But they have a drawback of requiring relatively expensive reagents. In order to apply the
fluorescent biosensor for detection of real samples with complex background, such as tracheal
and cloacal swabs from birds, further work would be required to combine an effective sample
pretreatment method with the fluorescent biosensor for the detection of AIVs in the field.
2.3. Electrochemical biosensors
More than half of the biosensors used for the detection of AIVs are based on electrochemical
transducers. Electrochemical biosensors use changes in the electrical properties caused by
biochemical reactions to detect an analyte [48]. Electrochemical transducers offer several
advantages: low cost, high sensitivity, ease of miniaturization, independence from solution
turbidity, low power requirements, and simplicity of use [49]. These characteristics make
electrochemical detection methods highly attractive for field monitoring of infectious diseases
and biological warfare agents. Electrochemical biosensors can be divided by the electrical
parameter that they measure: amperometric, potentiometric, conductimetric, and impedimet-
ric. Amperometric biosensors work by applying a constant potential across an electrode and
measuring the current associated with either the reduction or oxidation of an electroactive
species created by the interaction of the biological element and the analyte. Amperometric
biosensors are often used with an enzyme capable of catalyzing the production of an ionic
product and increasing the selectivity and the sensitivity [50]. Potentiometric biosensors gather
data by converting a biological reaction into a potential signal with the use of ion-selective
electrodes [51]. Conductimetric biosensors simply measure the conductivity change in a
medium caused by the analytes. Impedimetric biosensors measure a combination of the
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resistive and capacitive or inductive properties of a material in response to a small amplitude
sinusoidal excitation signal [52].
A detailed review of the electrochemical biosensors for detection of AIVs before year 2014 can
be found in the paper by Grabowska et al. [53], which covered the electrochemical genosensors
and electrochemical immunosensors for detection of AIVs. A total of 69 references were cited
in their review paper. Within the context of this chapter, the electrochemical biosensors
reported prior to 2014 are referred to the review paper by Grabowska et al. and the electro-
chemical biosensors reported in the years 2014 and 2015 plus some impedance biosensors not
mentioned by Grabowska et al. are reviewed in detail.
Impedance biosensors are a class of electrical biosensors that measure the electrical impedance
of an interface in AC steady state with constant DC bias conditions. This is accomplished by
imposing a sinusoidal voltage at a given frequency and measuring the current. This measure-
ment can be done over a range of frequencies or at a given frequency [54]. Many impedance
biosensors utilize a capture probe on the detecting surface to hold the target molecule, thereby
stabilizing the point of detection. Due to the ease of miniaturization, low energy usage and
relatively low cost, impedance biosensors show promise for AIVs applications. Impedance
biosensors can use a variety of biological sensing elements but the most commonly used are
antibodies. When using antibodies as the biological element the biosensor is often referred to
as an impedance immunosensor. Impedance immunosensors rely on the interaction of the
antibody and the antigen to generate a detectable signal for the transducing element. This
allows the immunosensor to detect either indirect or direct impedance measurements. Direct
impedance measurement, or label-free detection, is dependent on monitoring the changes in
the electrical properties of the sensing environment caused by the antibody-antigen interac-
tion. A label-free detection method has several advantages over an indirect detection method,
including reduced detection time, lower cost, and simpler detection protocol.
There are two general classes of impedance biosensors, Faradic and non-Faradic impedance
biosensor, which have been used for the detection of AIV H5N1 or subtype H5. A Faradic
impedance biosensor was developed by Wang and co-workers [55] using an interdigitated
array microelectrode. Polyclonal antibody against H5 was oriented immobilized on the gold
surface through protein A to capture target virus, and red blood cells (RBCs) were used as
biolabels for signal amplification. The biosensor had a lower detection limit of 103 EID50 ml−1.
Wang et al. [10] also reported a non-Faradic impedance biosensor for H5N2 avian influenza
detection, which was based on the combination of an immunomagnetic nanobeads separation
and a microfluidic chip with an interdigitated array microelectrode. A lower detection limit
of 103 EID50 ml−1 was achieved with detection time less than 1 h. Then, Lum et al. [56] further
improved the non-Faradic impedance biosensor for H5N1 detection by a combination of
immunomagnetic nanoparticles, a microfluidic chip, an interdigitated array microelectrode,
and RBCs for signal amplification. The specificity of the biosensor was improved due to the
use of anti-H5 as a capture antibody and anti-N1 as a detection antibody.
A miniaturized biosensor was developed by Diouani et al. [57] for the detection of H7N1.
Polyclonal antibodies against AIV H7N1 were attached to a gold electrode using a self-
assembled monolayer. The impedance measurement was carried out in the presence of a redox
Biosensors for Rapid Detection of Avian Influenza
http://dx.doi.org/10.5772/64353
73
probe and inside a Faraday cage. The lower detection limit of this biosensor was determined
to be 5 μg/ml of specific antigen. Hassen et al. [58] developed an impedance biosensor capable
of quantifying influenza A virus in a media comprised of numerous other proteins and viruses.
The biosensor had a lower detection limit of 8 ng/ml, even in the presence of nonspecific viruses
and proteins.
In Table 3, the electrochemical biosensors developed for the detection of AIVs in year 2014 and
2015 are summarized [59–79].
Influenza
subtype
Target Bioreceptor Sensitivity Detection
range
Reference
H1N1 Virus Antibody 1 pfu/ml 1–104 pfu/ml [65]
H5N1 HA Antibody 2.2 pg/ml 4–20 pg/ml [66]
H1N1 PB1-F2 protein Antibody 0.42 nM
(monomeric);
16 nM (oligomeric)
5 nM–1.5 μM
(monomeric);
5 nM–0.5 μM
(oligomeric)
[60]
H5N1 Virus Antibody 2−15
HAU/50 μl
2−15–2−8
HAU/50 μl
[67]
H5N2, H7N1,
H1N1
M1 protein Antibody 20 pg/ml
(80–100 virus/μl)
– [59]
H1N1 PB1-F2
protein
Antibody 0.42 nM 5 nM–1.5 μM [61]
H5N1 Antibody HA 2.1 pg/ml 4–20 pg/ml [63]
H5N1 Antibody HA 2.4 pg/ml 4–100 pg/ml [64]
H7N9 Virus Antibody 6.8 pg/ml 0.01–20
ng/ml
[68]
H5N1 Virus Antibody 2−1
HAU/50 μl
2−1–24
HAU/50 μl
[62]
H5N1 Complementary
DNA (20-mer);
RNA (280-mer)
Complementary
sequences
probe
73 pM (DNA
20-mer); 0.87 pM
(RNA 280-mer)
– [71]
H5N1 Full length
H5 gene
DNA probe fM level – [69]
H5N1 Full length
H5 gene
DNA probe 0.03 fM (20-
mer ssDNA); 0.08
fM (ds DNA)
– [70]
H7N9 A fragment
of the HA
gene sequence
DNA probe 100 fM – [72]
H7N9 A fragment
of the HA
Primer and
DNAzyme
9.4 fM 50 fM–100 pM [73]
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Influenza
subtype
Target Bioreceptor Sensitivity Detection
range
Reference
gene sequence
H5N1 Virus Aptamer 8 × 10−4 HAU/
200 μl
0.001–1 HAU [74]
H5N1 Virus Aptamer 0.0128 HAU 0.0128–12.8 HAU [78]
H5N1 Viral proteins Aptamer-
antibody pair
100 fM 100 fM–10 pM [75]
H5N1 Virus Aptamer 2−9 HAU 0.001–4 HAU [77]
H5N1 HA Glycan – – [76]
H5N1 HA Glycan aM level 140 aM–14 nM [79]
Table 3. A list of electrochemical biosensors reported in 2014 and 2015 for the detection of AIVs.
For the past two years, the immunosensors have been the dominant electrochemical biosensors
for detection of AIVs [59–68]. For example, universal anti-M1 antibodies, which allow detection
of all serotypes of influenza A virus, were used for the development of an universal immuno-
sensor for detection of the influenza A virus. It showed similar sensitivity (80–100 virus
particles/μl) to molecular methods [59]. Miodek and co-workers [60, 61] developed an
electrochemical immunosensor, which was based on conductive polypyrrole modified with
ferrocenyl groups as a redox marker for the detection of PB1-F2, a nonstructural accessory
protein of influenza A virus. Lin et al. [62] demonstrated that an impedance immunosensor,
which was based on low-cost microelectrodes and specific monoclonal antibodies for rapid
detection of AIV H5N1 in chicken swabs. Studies by Jarocka and co-workers [63, 64] revealed
that the immobilization of the recombinant His-tagged HA was able to detect antibodies
against AIV H5N1 in hen serum.
Although electrochemical biosensors for avian influenza detection have mostly been investi-
gated for whole virus or virus protein detection, some groups have developed biosensors for
the detection of avian influenza nucleic acid sequences [69–73]. These biosensors are based on
the use of nucleic acid probes, which bind to specific sequence in the influenza genome. Several
genosensors have been studied for the detection of the full length H5 gene of AIV H5N1. In
the study of genosensors by Grabowska et al. [69, 70], redox active compounds (such as cobalt
porphyrins or 3-iron bis(dicarbollide) were conjugated with the DNA probes, which were very
close to the electrode surface. These developed genosensors showed a sensitivity in the fM
range. Malecka and co-workers [71] reported an AET/Phen-Epoxy/Fe(III)/(Phen-Epoxy-NH2-
NC3)2 genosensor, which has a working principle similar to this already reported by Gra-
bowska et al. [69]. The hybridization process caused the formation of the duplex structure on
the electrode surface, which resulted in the thickness changes of the double layer at the
interface between the electrode and solution.
A new trend in the development of biosensors is the use of nanomaterials which exhibit unique
and attractive chemical, physical, and electronic properties. Various nanomaterials have been
used as an electrode platform in highly sophisticated electroanalytical biosensing devices. The
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working electrodes (actual physical transducers) upon modification with these materials gain
large effective surface area, high catalytic capabilities, and high conductivity. Thus, these
transducers could act as effective mediators and facilitate electron transfer between an active
site on the receptor and the electrode surface. Nanoparticles [74, 75], carbon nanotubes [65],
magnetic nanobeads [68, 74], or quantum dots [76] enhance sensitivity and selectivity of the
electrochemical detection. Among the variety of metal nanoparticles, gold nanoparticles
(GNPs) have been extensively utilized in recent years, mainly because of their nanoscopic size,
good conductivity, and biocompatibility. One of the most commonly used is single-walled (SW)
or multiwalled (MW) carbon nanotubes (CNTs) as well as graphene and graphene nanosheets.
Thanks to their fast electron transfer ability, mechanical strength, chemical stability, catalysis
effect, and thermal and electrical conductivity, they are attracting greater interest than other
applied technologies.
A magnetic nanobeads-based impedance aptasensor was designed and developed by Fu and
co-workers [74] (Figure 7). Briefly, H5N1 aptamers were coated on the magnetic nanobeads
(MBs) for specifically capturing target AIV H5N1. Then, bionanocomposites (BNCs) were
added using Au nanoparticles (AuNPs) as carriers, which were conjugated with concanavalin
A (ConA) and glucose oxidase (GOx). The BNCs attached on the captured target virus through
ConA-glycan interaction formed a sandwich complex. Finally, the sandwich complex was
transferred to a glucose solution, resulting in an efficient enzymatic reaction and the impedance
decreased correspondingly on a screen-printed interdigitated array electrode. This method
took advantages of the high efficiency of enzymatic catalysis and the high susceptibility of
electrochemical impedance on the ion strength and endowed the aptasensor with high
sensitivity.
Figure 7. Illustration of the aptasensing mechanism and construction of the aptasensor (with permission from ACS).
Wang and co-workers [77] developed an aptamer-based bifunctional bionanogate, which could
selectively respond to target molecules and control enzymatic reaction for electrochemical
measurements (Figure 8). A nanoporous gold film with a pore size of ~20 nm was prepared
by a metallic corrosion method and then was functionalized with two types of thiol-modified
single-stranded oligos (SH-ssDNAs) by means of Au–thiolate bonding. The bases of the two
immobilized SH-ssDNAs were selected to be partly complementary to that of the two ends of
an aptamer, respectively. Then, aptamers were added and hybridized with the two immobi-
lized SH-ssDNAs, resulting in the nanopore covered with aptamers, a “closed” bionanogate.
Finally, the aptamer covered nanopore film was placed onto an enzyme precoated glassy
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carbon electrode to form an aptasensor. The working principle of the bionanogate-based
aptasensor for detection of AIV H5N1 is illustrated in Figure 8. Initially, without the target
AIV, the bionanogate was kept “closed,” which isolated coenzymes and substrates in the
testing solution from the enzymes immobilized on the electrode so that the enzymatic reaction
was restricted (Figure 8a). Upon the target virus binding, the aptamers dissociated into
solution from their ssDNAs and formed aptamer–virus complexes, which triggered the
bionanogate “open” (Figure 8b). This “open” state allowed coenzymes and substrates to
diffuse freely through the opened nanopore and to create contact with the immobilized
enzymes, resulting in an efficient enzymatic reaction (Figure 8c).
Figure 8. Principle of the bionanogate-based aptasensor for detection of AIV H5N1 (with permission from Elsevier).
Despite the remarkable sensitivity, rapid response, miniaturization capability, and low cost of
the electrochemical biosensors for AIV detection, there are still problems with long-term
stability and selectivity in real samples with complex background. Obviously, further work
would be required to demonstrate that the electrochemical biosensors do not suffer from
stability and selectivity problems when handling real samples in the field.
3. Conclusion
Biosensors have attracted tremendous interest in AIVs detection. They are characterized by
good selectivity and sensitivity with a wide dynamic range from subfemtomolar to nanomolar,
easy and rapid experimental protocol, reasonable cost, and usage of the sample volume in a
μl range. Rapid development of nanotechnology has opened a new way for design and
construction of biosensors with even better features. However, many contributions to the field
of biosensors for AIVs detection still are at the “proof-of-concept” stage. Thus, authors hope
that this chapter will promote lively and valuable discussions in order to generate new ideas
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and make new approaches toward the development of innovative biosensors for applications
in AIVs detection.
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